Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study.
Assanto GM, Totaro M, Poggiali R, Delli Paoli A, Annechini G, D'Elia GM, Aji F, Petrucci L, Fazio F, Del Giudice I, Martelli M, Micozzi A, Gentile G.
Assanto GM, et al. Among authors: del giudice i.
Mediterr J Hematol Infect Dis. 2023 Nov 1;15(1):e2023061. doi: 10.4084/MJHID.2023.061. eCollection 2023.
Mediterr J Hematol Infect Dis. 2023.
PMID: 38028390
Free PMC article.
No abstract available.